| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10753-016-0343-1 |
| P698 | PubMed publication ID | 27075590 |
| P50 | author | Hamid Sharifi | Q44683637 |
| Gholamabbas Mohammadi | Q52145472 | ||
| Mohsen Saravani | Q59157301 | ||
| P2093 | author name string | B Kalantari-Khandani | |
| M M Yaghoobi | |||
| A Gholamhoseinian Najar | |||
| P2860 | cites work | Study of 5HT3 and HT4 receptor expression in HT29 cell line and human colon adenocarcinoma tissues | Q39734637 |
| Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells | Q39910109 | ||
| Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase | Q39945648 | ||
| Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells | Q40288602 | ||
| Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer | Q40333166 | ||
| Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer | Q40350277 | ||
| 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. | Q45980723 | ||
| 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway | Q46902088 | ||
| Direct Transcriptional Up-regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia | Q63362913 | ||
| Cyclooxygenase-2 is a neuronal target gene of NF-kappaB | Q24795366 | ||
| HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms | Q26778548 | ||
| HSP90 inhibition suppresses lipopolysaccharide-induced lung inflammation in vivo | Q27320833 | ||
| Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy | Q28195436 | ||
| NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target | Q28611413 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data | Q33411668 | ||
| Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells | Q33757073 | ||
| The Hsp90 chaperone complex as a novel target for cancer therapy | Q34217071 | ||
| The induction of S100p expression by the Prostaglandin E2(PGE2)/EP4 receptor signaling pathway in colon cancer cells | Q34616607 | ||
| Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors | Q34624887 | ||
| Opposite effect of phorbol ester PMA on PTGS2 and PGDH mRNA expression in human chorion trophoblast cells | Q34739513 | ||
| TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells | Q34977232 | ||
| Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract | Q35148940 | ||
| Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion | Q35563311 | ||
| COX-2 inhibition as a tool to treat and prevent colorectal cancer | Q35925958 | ||
| PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer | Q35963300 | ||
| Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages | Q36230620 | ||
| Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy | Q36559283 | ||
| New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. | Q37215989 | ||
| Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers | Q37485661 | ||
| 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1. | Q37549404 | ||
| 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy | Q37920360 | ||
| Multifaceted roles of PGE2 in inflammation and cancer | Q38045226 | ||
| Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships | Q38163980 | ||
| The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer | Q38210012 | ||
| Pharmacologic heat shock protein 70 induction confers cytoprotection against inflammation in gliovascular cells | Q38895909 | ||
| 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways | Q38915333 | ||
| PGE2-induced colon cancer growth is mediated by mTORC1. | Q38965450 | ||
| Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. | Q39109064 | ||
| Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death | Q39652497 | ||
| P433 | issue | 3 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 1116-1123 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells. | |
| P478 | volume | 39 |
Search more.